HC Wainwright reissued their buy rating on shares of PDS Biotechnology ( NASDAQ:PDSB – Get Rating ) in a research note issued to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $21.00 target price on the stock. PDSB has been the topic of several other research reports. B. Riley reissued a buy rating and set a $12.00 price objective on shares of PDS Biotechnology in a report on Wednesday. Noble Financial lifted their price objective on PDS Biotechnology to $19.

https://www.dailypolitical.com/2023/03/29/pds-biotechnologys-pdsb-buy-rating-reaffirmed-at-hc-wainwright.html

#dailypolitical